Replies to post #77945 on Ayala Pharmaceuticals Inc (fka ADXS)

[cdiddy01]

plan may be to raise a modest amount of cash now using a portion of the 30M shares, after some good news is released (Head & Neck IST start.)

Problem with that is this stock is not going to move up without either amazing NEO data or a big licensing deal to catapult it. It's at that point now.

[ignatiusrielly35]

Jck, I would rather see the company sold than issue 30m shares. I think the company would be foolish to refrain from licensing any HOT indications at all until data is available. I would be okay with licensing one or two now to raise cash and then waiting. I do not see raising a measly $30m with 60% dilution as an acceptable option whatsoever.